금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Iran replaces top security official at crucial moment in talks over Strait of Hormuz
Mohsen Rezaei appointed head of Supreme National Security Council after Mohammad Bagher Zolghadr ste...
U.S. stock futures flat as investors await inflation data, grapple with more Iran uncertainty
U.S. stock-index futures were little changed on Sunday, after new demands from Iran raised fresh dou...
Merck lifts sales forecast as newer drugs gain momentum
The stock market’s brutal summer reset is finally over. Here is why Citadel Securities says it is time to buy again.
Citadel Securities strategist Scott Rubner said markets have gotten a “technical reset” and is ready to recommend buying stocks again.
Ametek beats top-line and bottom-line estimates; gives Q3 and updates FY26 outlook
Versigent PLC Non-GAAP EPS of $1.92 beats by $0.48, revenue of $2.45B beats by $120M
USA Compression Partners GAAP EPS of $0.31 beats by $0.04, revenue of $342.1M beats by $1.74M
Earnings Snapshot: Pfizer targets $2.5B in added cost savings as outlook misses estimates
Markets swing to upside, again
USD: Sep '26 is Up at 99.905.
Kimco Realty beats Q2 street estimates, raises outlook
OXY Stock: When A Bargain Price Is A Message
This energy giant looks cheap after a pullback, but the market's discount may be a deliberate verdict on a business facing serious questions.
Stock Markets Had a Perfect Summer’s Day, Now the Heat Is On
Palantir beats expectations, White House to review AI security risks, Snap gathering optimism, and more news to start your day.
Gold Price Forecast: XAU/USD remains sideways around $4,050 during US NFP week
Gold price (XAU/USD) remains in a tight range at around $4,050 during the European trading session on Tuesday. The precious metal struggles to get direction, with investors awaiting the United States ...
Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?
The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.